| Balance Sheets | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Cash and cash equivalents | 110,930 | 75,154 | ||
| Marketable debt securities, at fair value | 143,600 | 244,383 | ||
| Accounts receivable, net | 82,984 | 38,718 | ||
| Inventory | 5,548 | 4,090 | ||
| Prepaid expenses and other current assets | 28,048 | 17,222 | ||
| Total current assets | 371,110 | 379,567 | ||
| Long-term inventory | 31,999 | 33,590 | ||
| Property and equipment, net | 4,320 | 4,561 | ||
| Operating lease right of use assets | 11,464 | 12,336 | ||
| Intangible assets, net | 109,435 | 105,607 | ||
| Other assets | 10,253 | 19,648 | ||
| Total assets | 538,581 | 555,309 | ||
| Accounts payable | 18,225 | 19,134 | ||
| Accrued expenses | 105,762 | 81,682 | ||
| Convertible debt, current portion | 0 | 68,838 | ||
| Operating lease liabilities, current portion | 5,734 | 5,595 | ||
| Other current liabilities | 5,353 | 14,291 | ||
| Total current liabilities | 135,074 | 189,540 | ||
| Convertible debt, less current portion | 311,370 | 311,016 | ||
| Operating lease liabilities, less current portion | 12,645 | 14,124 | ||
| Other non-current liabilities | 5,928 | 7,882 | ||
| Total liabilities | 465,017 | 522,562 | ||
| Common stock 0.0001 par value 200,000,000 shares authorized 89,456,626, and 87,452,835 issued and outstanding as of september 30, 2025 and december 31, 2024, respectively | 9 | 9 | ||
| Additional paid-in capital | 1,550,051 | 1,534,698 | ||
| Accumulated deficit | -1,475,442 | -1,501,148 | ||
| Accumulated other comprehensive loss | -1,054 | -812 | ||
| Total stockholders' equity | 73,564 | 32,747 | ||
| Total liabilities and stockholders' equity | 538,581 | 555,309 | ||
Travere Therapeutics, Inc. (TVTX)
Travere Therapeutics, Inc. (TVTX)